Re OL, Lopez-Lopez V, Balaguer-Roman A, Martinez-Sanchez MA, Eshmuminov D, Llamoza-Torres CJ, Miura K, Baroja-Mazo A, Ramirez P, Robles-Campos R, Ramos-Molina B. New challenges in cholangiocarcinoma candidates for elective surgery: harnessing the microbiome dysbiosis. Langenbecks Arch Surg. 2023 Mar 31;408(1):134. doi: 10.1007/s00423-023-02867-8. PubMed PMID: 37000331.

Journal: LANGENBECKS ARCHIVES OF SURGERY
AÑO: 2023; IF: 2.895

37000331

Alfaro R, Llorente S, Gonzalez-Martinez G, Jimenez-Coll V, Martinez-Banaclocha H, Galian JA, Botella C, Moya-Quiles MR, de la Pena-Moral J, Minguela A, Legaz I, Muro M. Clinical Significance of the Pre-Transplant CXCR3 and CCR6 Expression on T Cells In Kidney Graft Recipients. Transplant Proc. 2023 Jan 6:S0041-1345(22)00883-1. doi: 10.1016/j.transproceed.2022.12.012. Online ahead of print. PubMed PMID: 36621349.

Journal: TRANSPLANTATION PROCEEDINGS
AÑO: 2023; IF: 1.014

36621349

Millet V, Gensollen T, Maltese M, Serrero M, Lesavre N, Bourges C, Pitaval C, Cadra S, Chasson L, Vu Man TP, Masse M, Martinez-Garcia JJ, Tranchida F, Shintu L, Mostert K, Strauss E, Lepage P, Chamaillard M, Broggi A, Peyrin-Biroulet L, Grimaud JC, Naquet P, Galland F. Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis. Gut. 2022 Sep 29. pii: gutjnl-2021-325792. doi: 10.1136/gutjnl-2021-325792. [Epub ahead of print] PubMed PMID: 36175116.

Journal: GUT
AÑO: 2022; IF: 31.793

36175116

Lambris JD, Rosenthal A, Pelegrin P, Tremblay ME, Chen P. The future of neuroimmunology research for CNS disease therapeutics. Trends Pharmacol Sci. 2022 Aug;43(8):611-614. doi: 10.1016/j.tips.2022.06.003. No abstract available. PubMed PMID: 35839748.

Journal: TRENDS IN PHARMACOLOGICAL SCIENCES
AÑO: 2022; IF: 17.638

35839748

Coll RC, Schroder K, Pelegrin P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol Sci. 2022 Aug;43(8):653-668. doi: 10.1016/j.tips.2022.04.003. Epub 2022 May 3. PubMed PMID: 35513901.

Journal: TRENDS IN PHARMACOLOGICAL SCIENCES
AÑO: 2022; IF: 17.638

35513901